Evaluation of Saliva as a Matrix for RT-PCR Analysis and Two Rapid Antigen Tests for the Detection of SARS-CoV-2.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
30 08 2022
Historique:
received: 12 08 2022
revised: 25 08 2022
accepted: 26 08 2022
entrez: 23 9 2022
pubmed: 24 9 2022
medline: 28 9 2022
Statut: epublish

Résumé

The use of saliva for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sparks debate due to presumed lower sensitivity and lack of standardization. Our aim was to evaluate the performance characteristics of (i) saliva collected by the ORAcollect

Identifiants

pubmed: 36146737
pii: v14091931
doi: 10.3390/v14091931
pmc: PMC9502549
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Front Immunol. 2022 Jan 27;13:751705
pubmed: 35154094
N Engl J Med. 2020 Sep 24;383(13):1283-1286
pubmed: 32857487
PLoS One. 2021 Dec 22;16(12):e0260894
pubmed: 34936659
NPJ Digit Med. 2020 Apr 14;3:55
pubmed: 32337371
Clin Microbiol Infect. 2021 Feb;27(2):285.e1-285.e4
pubmed: 32422408
Viruses. 2022 Aug 30;14(9):
pubmed: 36146737
JAMA. 2021 Sep 21;326(11):1065-1067
pubmed: 34387653
Microorganisms. 2021 Sep 09;9(9):
pubmed: 34576805
Diagnostics (Basel). 2022 Jan 04;12(1):
pubmed: 35054277
Lancet Infect Dis. 2020 May;20(5):565-574
pubmed: 32213337
J Virol Methods. 2022 Feb;300:114381
pubmed: 34843826
Viruses. 2021 Jul 27;13(8):
pubmed: 34452325
Int J Infect Dis. 2022 Jun;119:38-40
pubmed: 35364282
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
Microorganisms. 2021 Apr 10;9(4):
pubmed: 33920307
J Mol Diagn. 2021 Oct;23(10):1249-1258
pubmed: 34358676
Emerg Microbes Infect. 2020 Dec;9(1):1356-1359
pubmed: 32459137
J Infect Chemother. 2020 Oct;26(10):1086-1089
pubmed: 32571647
Sci Transl Med. 2021 Jan 20;13(577):
pubmed: 33288662

Auteurs

Julie De Meyer (J)

Department Microbiology, Laboratory Medicine, Antwerp University Hospital (UZA), 2650 Edegem, Belgium.

Hanne Goris (H)

Department Microbiology, Laboratory Medicine, Antwerp University Hospital (UZA), 2650 Edegem, Belgium.

Olivier Mortelé (O)

Department Microbiology, Laboratory Medicine, Antwerp University Hospital (UZA), 2650 Edegem, Belgium.

An Spiessens (A)

Department Microbiology, Laboratory Medicine, Antwerp University Hospital (UZA), 2650 Edegem, Belgium.

Guy Hans (G)

Mobile Testing Team, Antwerp University Hospital (UZA), 2650 Edegem, Belgium.

Hilde Jansens (H)

Department Microbiology, Laboratory Medicine, Antwerp University Hospital (UZA), 2650 Edegem, Belgium.

Herman Goossens (H)

Department Microbiology, Laboratory Medicine, Antwerp University Hospital (UZA), 2650 Edegem, Belgium.

Veerle Matheeussen (V)

Department Microbiology, Laboratory Medicine, Antwerp University Hospital (UZA), 2650 Edegem, Belgium.

Sarah Vandamme (S)

Department Microbiology, Laboratory Medicine, Antwerp University Hospital (UZA), 2650 Edegem, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH